First Time Loading...
K

Kidswell Bio Corporation
TSE:4584

Watchlist Manager
Kidswell Bio Corporation
TSE:4584
Watchlist
Price: 136 JPY 0.74% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Kidswell Bio Corporation

Wall Street analysts forecast Kidswell Bio Corporation stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kidswell Bio Corporation is 816 JPY with a low forecast of 808 JPY and a high forecast of 840 JPY.

Lowest Forecast
Wall Street Target
808 JPY
494% Upside
Average Forecast
Wall Street Target
816 JPY
500% Upside
Highest Forecast
Wall Street Target
840 JPY
518% Upside
Lowest
Price Target
808 JPY
494% Upside
Average
Price Target
816 JPY
500% Upside
Highest
Price Target
840 JPY
518% Upside
Kidswell Bio Corporation Competitors:
Price Targets
HARP
Harpoon Therapeutics Inc
8% Upside
ADMA
ADMA Biologics Inc
30% Upside
PRAX
Praxis Precision Medicines Inc
158% Upside
B
600161
Beijing Tiantan Biological Products Corp Ltd
14% Upside
HARP
Harpoon Therapeutics Inc
8% Upside
ADMA
ADMA Biologics Inc
30% Upside
PRAX
Praxis Precision Medicines Inc
158% Upside
B
600161
Beijing Tiantan Biological Products Corp Ltd
14% Upside
6855
Ascentage Pharma Group International
81% Upside
AGEN
Agenus Inc
52% Downside
BIIB
Biogen Inc
47% Upside
4978
ReproCell Inc
100% Upside

Revenue
Forecast

Revenue Estimate
Kidswell Bio Corporation

For the last 8 years the compound annual growth rate for Kidswell Bio Corporation's revenue is 31%. The projected CAGR for the next 2 years is 12%.

31%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Kidswell Bio Corporation

Operating Income forecast
is not available for
Kidswell Bio Corporation

Net Income
Forecast

Net Income Estimate
Kidswell Bio Corporation

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Kidswell Bio Corporation's stock price target?
Price Target
816 JPY

According to Wall Street analysts, the average 1-year price target for Kidswell Bio Corporation is 816 JPY with a low forecast of 808 JPY and a high forecast of 840 JPY.

What is Kidswell Bio Corporation's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Kidswell Bio Corporation's revenue is 31%. The projected CAGR for the next 2 years is 12%.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.